RHHVF

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Roche Holding AG

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
CEO
Severin Schwan
Employees
0
Headquarters

Grenzacherstrasse 124
Basel, Basel-Stadt (Basle
Phone: 41.61.688.11.11
http://www.roche.com

News

Hookipa to receive $10M from Roche as FDA clears cancer trial
Apr 24, 2024 18:01pm

No summary available.


Source:Seeking Alpha
Roche prepares for business after boom from COVID-related products
Apr 24, 2024 10:51am

The Swiss pharmaceutical company reiterated its outlook, predicting single-digit growth this year, following an end to the slump in COVID-19-related sales.


Source:MarketWatch
Roche Q1 sales fall amid strong Swiss franc, weak COVID-19 medicine sales
Apr 24, 2024 10:27am

https://www.investing.com/news/stock-market-news/roche-q1-sales-fall-amid-strong-swiss-franc-weak-covid19-medicine-sales-3392989


Source:Investing.com
Roche to Meet Full-Year Hopes as Sales Beat Forecasts
Apr 24, 2024 06:41am

Roche first-quarter sales declined on weak demand for its Covid-19 products and currency headwinds but it remained confident of meeting its full-year guidance.


Source:The Wall Street Journal
Swiss pharma giant Roche''s first-quarter sales edge higher as its emerges from post-Covid-19 slump
Apr 24, 2024 05:58am

Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19 products and a number of its cancer drugs.


Source:CNBC
Roche Q1 sales down 6% on forex effect, loss of COVID revenue
Apr 24, 2024 05:52am

FRANKFURT (Reuters) - Roche said on Wednesday its first-quarter sales slipped 6% as the loss on COVID-19 related revenue was partly offset by further …


Source:KFGO
Roche’s therapy shows promise in slowing Parkinson’s disease motor progression: GlobalData
Apr 23, 2024 10:32am

… ) 2024 annual meeting, Roche presented positive outcomes from … observational study,” Lorraine Palmer, Pharma Analyst at GlobalData, said in … between branded and generic drugs : GlobalData From Paracetamol … the external control, Roche applied the same inclusion …


Source:EIN News Pharmaceuticals
Novartis Raises Forecast as Sales of New Blockbusters Climb
Apr 23, 2024 05:56am

… year on developing new drugs, Novartis dispatched teams to … , Bloomberg (Bloomberg) -- Novartis AG raised its forecast as … The drugmaker proposed former Bristol-Myers Squibb Co. chairman Giovanni Caforio … rival Roche Holding AG. Read More: Swiss Pharma Giants …


Source:EIN News Pharmaceuticals
GlobalData : Roche''s PRX-002 shows promise in slowing Parkinson''s disease motor progression, says GlobalData
Apr 20, 2024 07:47am

… ) 2024 annual meeting, Roche presented positive four-year results … analytics company. Lorraine Palmer, Pharma Analyst at GlobalData, comments: … to the external control, Roche applied the same inclusion … the results presented by Roche should still be treated …


Source:EIN News Pharmaceuticals
Roche''s Alecensa gets US FDA approval for adjuvant treatment for people with ALK─positive early─stage lung cancer
Apr 20, 2024 05:50am

… Ministry of Health (IMoH) Pharmaceutical Administration, Switzerland’s Swissmedic, … a member of the Roche Group, Kamakura Research Laboratories … to combat the disease. Roche is committed to improving … manufacturers of branded medicines, Roche has grown into the …


Source:EIN News Pharmaceuticals